Prevention of Postoperative Infections after Lung Resection with Probiotics
- Conditions
- Postoperative infections after lung resectionpostoperative infections, lung resectionD013530
- Registration Number
- JPRN-jRCTs061230048
- Lead Sponsor
- Hamano Kimikazu
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 700
(1) Outpatients or hospitalized patients scheduled for thoracoscopic anatomical lung resection (lobectomy or segmentectomy) for pulmonary lesions
(2) Patients suspected of primary lung cancer by CT or PET-CT, or diagnosed with primary lung cancer by bronchoscopy or CT-guided biopsy
(3) Patients aged 20 years or older at the time of informed consent
(4) Patients who have given written informed consent of their own free will after receiving sufficient explanation about participating in this study
(1) Patients with a history of allergy to probiotics
(2) Patients with a history of side effects due to oral administration of probiotics
(3) Patients who have already received continuous administration of probiotics
(4) Patients who are currently taking probiotics regularly as guidance-required or over-the-counter drugs
(5) Patients undergoing treatment for any infectious disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method